Antibacterial ligands

T-2307, an arylamidine, has antifungal activities in vitro and in vivo. T-2307 exhibits broad-spectrum activity against clinically significant pathogens, including Candida species (MIC range, 0.00025 to 0.0078 μg/ml), Cryptococcus neoformans (MIC

T-2307, an arylamidine, has antifungal activities in vitro and in vivo. T-2307 exhibits broad-spectrum activity against clinically significant pathogens, including Candida species (MIC range, 0.00025 to 0.0078 μg/ml), Cryptococcus neoformans (MIC

VT-1598 is an orally active and selective fungal inhibitor targeting CYP51. VT-1598 shows anti-fungal activity against Candida auris.In VitroVT-1598 (0.015-8 μg/mL: 24 h) demonstrates in vitro activity against C. auris. VT-1598 (0.03125-0.125 μg/mL:

VT-1598 is an orally active and selective fungal inhibitor targeting CYP51. VT-1598 shows anti-fungal activity against Candida auris.In VitroVT-1598 (0.015-8 μg/mL: 24 h) demonstrates in vitro activity against C. auris. VT-1598 (0.03125-0.125 μg/mL:

VT-1598 is an orally active and selective fungal inhibitor targeting CYP51. VT-1598 shows anti-fungal activity against Candida auris.In VitroVT-1598 (0.015-8 μg/mL: 24 h) demonstrates in vitro activity against C. auris. VT-1598 (0.03125-0.125 μg/mL: